99
Views
12
CrossRef citations to date
0
Altmetric
Original Article

Relationship of DNA Ploidy and S-Phase Fraction to Survival After First Recurrence of Breast Cancer

, , , , , & show all
Pages 423-429 | Accepted 30 Mar 1994, Published online: 08 Jul 2009

References

  • Cutler S J, Asire A J, Taylor S G, III. Classification of patients with disseminated cancer of the breast. Cancer 1969; 24: 861–9
  • Devitt J E. The enigmatic behavior of breast cancer. Cancer 1971; 27: 12–7
  • Clark G M, Sledge G W, Jr, Osborne C K. Survival from first recurrence: Relative importance of prognostic factors in 1 015 breast cancer patients. J Clin Oncol 1987; 5: 55–61
  • Shek L LM, Godolphin W, Spinelli J J. Oestrogen receptors, nodes and stage as predictors of post-recurrence survival in 457 breast cancer patients. Br J Cancer 1987; 56: 825–9
  • Koenders P G, Beex L VAM, Kloppenborg P WC, Smals A GH, Benraad Th J, the Breast Cancer Study Group. Human breast cancer: survival from first metastasis. Breast Cancer Res Treat 1992; 21: 173–80
  • Tubiana M, Pejovic M H, Chavaudra N. The long-term prognostic significance of the thymidine labelling index in breast cancer. Int J Cancer 1984; 33: 441–5
  • Klintenberg C, Stål O, Nordenskjöld B. Proliferative index, cytosol estrogen receptor and axillary node status as prognostic predictors in human mammary carcinoma. Breast Cancer Res Treat 1986; 7(Suppl)99–106
  • Silvestrini R, Daidone M G, Di Fronzo G. Prognostic implication of labeling index versus estrogen receptors and tumor size in node-negative breast cancer. Breast Cancer Res Treat 1986; 7: 161–9
  • Cornelisse C J, van de Velde C JH, Caspers R JC. DNA ploidy and survival in breast cancer patients. Cytometry 1987; 8: 225–34
  • Harvey J, de Klerk N, Berryman I. Nuclear DNA content and prognosis in human breast cancer: a static cy-tophotometric study. Breast Cancer Res Treat 1987; 9: 101–9
  • Kallioniemi O-P, Blanco G, Alavikko M. Tumour DNA ploidy as an independent prognostic factor in breast cancer. Br J Cancer 1987; 56: 637–42
  • Meyer J S, Province M. Proliferative index of breast carcinoma by thymidine labelling: prognostic power independent of stage, estrogen and progesterone receptors. Breast Cancer Res Treat 1988; 12: 191–204
  • Stål O, Wingren S, Carstensen J. Prognostic value of DNA ploidy and S-phase fraction in relation to estrogen receptor content and clinicopoathological variables in primary breast cancer. Eur J Cancer Clin Oncol 1989; 25: 301–9
  • von Rosen A, Rutqvist L E, Carstensen J. Prognostic value of nuclear DNA content in breast cancer in relation to tumour size, nodal status and estrogen receptor content. Breast Cancer Res Treat 1989; 13: 23–32
  • Hatschek T, Fagerberg G, Stål O. Cytometric characterization and clinical course of breast cancer diagnosed in a population based screening program. Cancer 1989; 64: 1074–81
  • Sigurdsson H, Baldetorp B, Borg Å. Indicators of prognosis in node-negative breast cancer. N Engl J Med 1990; 322: 1045–53
  • Fernö M, Baldetorp B, Borg Å, Olsson H, Sigurdsson H, Killander K. Flow cytometric DNA index and S-phase fraction in breast cancer in relation to other prognostic variables and to clinical outcome. Acta Oncol 1992; 31: 157–65
  • Stål O, Carstensen J, Hatschek Nordenskjöld T. Significance of S-phase fraction and hormone receptor content in the management of young breast cancer patients. Br J Cancer 1992; 66: 706–11
  • Hedley D W, Rugg C A, Ng A BP. Influence of cellular DNA content on disease-free survival of stage II breast cancer patients. Cancer Res 1984; 44: 5395–8
  • Silvestrini R, Daidone M G, Gasparini G. Cell kinetics as a prognostic marker in node-negative breast cancer. Cancer 1985; 56: 1982–7
  • Stuart-Harris R, Hedley D W, Taylor I W. Tumour ploidy, response and survival in patients receiving endocrine therapy for advanced breast cancer. Br J Cancer 1985; 51: 573–6
  • Baildam A D, Zaloudik J, Howell A. DNA analysis by flow cytometry, response to endocrine treatment and prognosis in advanced carcinoma of the breast. Br J Cancer 1987; 55: 553–9
  • Blanco G, Holli K, Heikkinen M, Kallioniemi O-P, Taskinen P. Prognostic factors in recurrent breast cancer: relationships to site of recurrence, disease-free interval, female sex steroid receptors, ploidy and histological malignancy grading. Br J Cancer 1990; 62: 142–6
  • Meyer J S, Lee J Y. Relationships of S-phase fraction of breast carcinoma in relapse to duration of remission, estrogen receptor content, therapeutic responsiveness, and duration of survival. Cancer Res 1980; 40: 1890–6
  • Hatschek T, Carstensen J, Fagerberg G, Stäl O, Gröntoft O, Nordenskjöld B. Influence of S-phase fraction on metastatic pattern and post-recurrence survival in a randomized mammography screening trial. Breast Cancer Res and Treat 1989; 14: 321–7
  • Vindelöv L L, Christensen I BJ, Nissen N I. A detergent-trypsin method for the preparation of nuclei for flow cytometric DNA analysis. Cytometry 1983; 3: 323–7
  • Vindelöv L L, Christensen I BJ, Nissen N I. Standardization of high resolution flow cytometric DNA analysis by the simultaneous use of chicken and trout red blood cells as internal standards. Cytometry 1983; 3: 328–31
  • Wrange Ö, Nordenskjöld B, Gustafsson J-Å. Cytosol estra-diol receptor in human mammary carcinoma: an assay on isoelectric focussing in polyacrylamide gel. Anal Biochem 1978; 85: 461–75
  • Kaplan E L, Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc 1958; 53: 457–81
  • Cox D R. Regression models and life tables (with discussion). J R Statist Soc B 1972; 34: 187–220

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.